Outcomes of routine ilioinguinal lymph node dissection for palpable inguinal melanoma nodal metastasis

被引:13
作者
Glover, A. R. [1 ,2 ]
Allan, C. P. [3 ]
Wilkinson, M. J. [4 ]
Strauss, D. C. [4 ]
Thomas, J. M. [4 ]
Hayes, A. J. [4 ]
机构
[1] Royal N Shore Hosp, Kolling Inst Med Res, Sydney, NSW, Australia
[2] Univ Sydney, Sydney, NSW 2006, Australia
[3] Univ Queensland, Sch Med, Brisbane, Qld, Australia
[4] Royal Marsden Hosp, Sarcoma & Melanoma Unit, London SW3 6JJ, England
关键词
CUTANEOUS MELANOMA; SURGICAL-MANAGEMENT; SURVIVAL; GROIN; PROGNOSIS; BIOPSY; EXTENT;
D O I
10.1002/bjs.9502
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Patients who present with palpable inguinal melanoma nodal metastasis have two surgical options: inguinal or ilioinguinal lymph node dissection. Indications for either operation remain controversial. This study examined survival and recurrence outcomes following ilioinguinal dissection for patients with palpable inguinal nodal metastasis, and assessed the incidence and preoperative predictors of pelvic nodal metastasis. Methods: This was a retrospective clinicopathological analysis of consecutive surgical patients with stage III malignant melanoma. All patients underwent a standardized ilioinguinal dissection at a specialist tertiary oncology hospital over a 12-year period (1998-2010). Results: Some 38.9 per cent of 113 patients had metastatic pelvic nodes. Over a median follow-up of 31 months, the 5-year overall survival rate was 28 per cent for patients with metastatic inguinal and pelvic nodes, and 51 per cent for those with inguinal nodal metastasis only (P = 0.002). The nodal basin control rate was 88.5 per cent. Despite no evidence of pelvic node involvement on preoperative computed tomography (CT), six patients (5.3 per cent) with a single metastatic inguinal lymph node had metastatic pelvic lymph nodes. Logistic regression analysis showed that the number of metastatic inguinal nodes (odds ratio 1.56; P = 0.021) and suspicious CT findings (odds ratio 9.89; P = 0.001) were both significantly associated with metastatic pelvic nodes. The specificity of CT was good (89.2 per cent) in detecting metastatic pelvic nodes, but the sensitivity was limited (57.9 per cent). Conclusion: Metastatic pelvic nodes are common when palpable metastatic inguinal nodes are present. Long-term survival can be achieved following their resection by ilioinguinal dissection. As metastatic pelvic nodes cannot be diagnosed reliably by preoperative CT, patients presenting with palpable inguinal nodal metastasis should be considered for ilioinguinal dissection.
引用
收藏
页码:811 / 819
页数:9
相关论文
共 32 条
[1]   ILIOINGUINAL LYMPH NODE DISSECTION FOR PALPABLE METASTATIC MELANOMA TO THE GROIN [J].
Allan, Christopher P. ;
Hayes, Andrew J. ;
Thomas, J. Meirion .
ANZ JOURNAL OF SURGERY, 2008, 78 (11) :982-986
[2]  
[Anonymous], STUD BRAF INH DABR C
[3]  
*AUSTR NZ MEL TRIA, PROP TRIAL 1 ANZMTG
[4]   Pelvic lymph node dissection is beneficial in subsets of patients with node-positive melanoma [J].
Badgwell, Brian ;
Xing, Yan ;
Gershenwald, Jeffrey E. ;
Lee, Jeffrey E. ;
Mansfield, Paul F. ;
Ross, Merrick I. ;
Cormier, Janice N. .
ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (10) :2867-2875
[5]   Multivariate Analysis of Prognostic Factors Among 2,313 Patients With Stage III Melanoma: Comparison of Nodal Micrometastases Versus Macrometastases [J].
Balch, Charles M. ;
Gershenwald, Jeffrey E. ;
Soong, Seng-jaw ;
Thompson, John F. ;
Ding, Shouluan ;
Byrd, David R. ;
Cascinelli, Natale ;
Cochran, Alistair J. ;
Coit, Daniel G. ;
Eggermont, Alexander M. ;
Johnson, Timothy ;
Kirkwood, John M. ;
Leong, Stanley P. ;
McMasters, Kelly M. ;
Mihm, Martin C., Jr. ;
Morton, Donald L. ;
Ross, Merrick I. ;
Sondak, Vernon K. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (14) :2452-2459
[6]   Final Version of 2009 AJCC Melanoma Staging and Classification [J].
Balch, Charles M. ;
Gershenwald, Jeffrey E. ;
Soong, Seng-jaw ;
Thompson, John F. ;
Atkins, Michael B. ;
Byrd, David R. ;
Buzaid, Antonio C. ;
Cochran, Alistair J. ;
Coit, Daniel G. ;
Ding, Shouluan ;
Eggermont, Alexander M. ;
Flaherty, Keith T. ;
Gimotty, Phyllis A. ;
Kirkwood, John M. ;
McMasters, Kelly M. ;
Mihm, Martin C., Jr. ;
Morton, Donald L. ;
Ross, Merrick I. ;
Sober, Arthur J. ;
Sondak, Vernon K. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (36) :6199-6206
[7]   Cost-effectiveness of Adding FDG-PET or CT to the Diagnostic Work-up of Patients With Stage III Melanoma [J].
Bastiaannet, Esther ;
Uyl-de Groot, Carin A. ;
Brouwers, Adrienne H. ;
van der Jagt, Eric J. ;
Hoekstra, Otto S. ;
Oyen, Wim ;
Verzijlbergen, Fred ;
van Ooijen, Bart ;
Thompson, John F. ;
Hoekstra, Harald J. .
ANNALS OF SURGERY, 2012, 255 (04) :771-776
[8]   Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation [J].
Chapman, Paul B. ;
Hauschild, Axel ;
Robert, Caroline ;
Haanen, John B. ;
Ascierto, Paolo ;
Larkin, James ;
Dummer, Reinhard ;
Garbe, Claus ;
Testori, Alessandro ;
Maio, Michele ;
Hogg, David ;
Lorigan, Paul ;
Lebbe, Celeste ;
Jouary, Thomas ;
Schadendorf, Dirk ;
Ribas, Antoni ;
O'Day, Steven J. ;
Sosman, Jeffrey A. ;
Kirkwood, John M. ;
Eggermont, Alexander M. M. ;
Dreno, Brigitte ;
Nolop, Keith ;
Li, Jiang ;
Nelson, Betty ;
Hou, Jeannie ;
Lee, Richard J. ;
Flaherty, Keith T. ;
McArthur, Grant A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (26) :2507-2516
[9]  
COIT DG, 1989, ARCH SURG-CHICAGO, V124, P162
[10]   The future incidence of cutaneous melanoma within the UK [J].
Diffey, BL .
BRITISH JOURNAL OF DERMATOLOGY, 2004, 151 (04) :868-872